BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22883346)

  • 1. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report.
    Morris MI; Daly JS; Blumberg E; Kumar D; Sester M; Schluger N; Kim SH; Schwartz BS; Ison MG; Humar A; Singh N; Michaels M; Orlowski JP; Delmonico F; Pruett T; John GT; Kotton CN
    Am J Transplant; 2012 Sep; 12(9):2288-300. PubMed ID: 22883346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis transmission across three states: The story of a solid organ donor born in an endemic country, 2018.
    Jones JM; Vikram HR; Lauzardo M; Hill A; Jones J; Haley C; Seaworth B; Oldham S; Brown M; Gutierrez F; Basavaraju SV
    Transpl Infect Dis; 2020 Dec; 22(6):e13357. PubMed ID: 32510808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan.
    Chiang CY; Chen CH; Feng JY; Chiang YJ; Huang WC; Lin YJ; Huang YW; Wu HH; Lee PH; Lee MC; Shu CC; Wang HH; Wang JY; Wu MY; Lee CY; Wu MS
    J Formos Med Assoc; 2023 Oct; 122(10):976-985. PubMed ID: 37183074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.
    Malinis M; La Hoz RM; Vece G; Annambhotla P; Aslam S; Basavaraju SV; Bucio J; Danziger-Isakov L; Florescu DF; Jones JM; Rana M; Wolfe CR; Michaels MG
    Transpl Infect Dis; 2022 Apr; 24(2):e13800. PubMed ID: 35064737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome of latent tuberculosis in living renal transplant donors.
    Habhab WT; Alraddadi BM; Idris N; Alghamdi S; Zabani N; Fahmy A; Malik AA; Alwaassia M
    Saudi J Kidney Dis Transpl; 2019; 30(1):151-152. PubMed ID: 30804276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterial infections in solid organ transplant recipients.
    Meije Y; Piersimoni C; Torre-Cisneros J; Dilektasli AG; Aguado JM;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():89-101. PubMed ID: 24707957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges.
    Subramanian AK
    Curr Opin Infect Dis; 2014 Aug; 27(4):316-21. PubMed ID: 24977684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation-transmitted tuberculosis--Oklahoma and Texas, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):333-6. PubMed ID: 18385639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived tuberculosis after solid organ transplantation in two patients and a staff member.
    Bucher JN; Schoenberg MB; Freytag I; Lange U; Hofmann-Thiel S; Guba MO; Werner J; Eder A; Schelling G; Stangl M
    Infection; 2016 Jun; 44(3):365-70. PubMed ID: 26498284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterial infections in solid organ transplant recipients.
    Rashid HU; Begum NAS; Kashem TS
    Korean J Transplant; 2021 Dec; 35(4):208-217. PubMed ID: 35769848
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk stratification and management of QuantiFERON-positive solid-organ living donors.
    Gibb J; Wong D
    Curr Opin Organ Transplant; 2020 Aug; 25(4):351-356. PubMed ID: 32618720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review.
    Abad CLR; Razonable RR
    Transpl Infect Dis; 2018 Oct; 20(5):e12971. PubMed ID: 30055041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.
    Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA
    Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.
    Jensen TO; Darley DR; Goeman EE; Shaw K; Marriott DJ; Glanville AR
    Transpl Infect Dis; 2016 Oct; 18(5):782-784. PubMed ID: 27459235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of tuberculosis in deceased-organ donors and transmission risk to recipients in Spain.
    Coll E; Torre-Cisneros J; Calvo R; Garrido G; Matesanz R
    Transplantation; 2013 Jul; 96(2):205-10. PubMed ID: 23774810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.
    Bumbacea D; Arend SM; Eyuboglu F; Fishman JA; Goletti D; Ison MG; Jones CE; Kampmann B; Kotton CN; Lange C; Ljungman P; Milburn H; Morris MI; Muller E; Muñoz P; Nellore A; Rieder HL; Sester U; Theodoropoulos N; Wagner D; Sester M
    Eur Respir J; 2012 Oct; 40(4):990-1013. PubMed ID: 22496318
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.